Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$57.27 0.80 | 1.42%
05/22/13 - 09:40 AM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 9.70B 8.39B 7.95B 7.01B
Cost of Sales 2.19B 1.82B 1.60B 1.38B
Gross Operating Profit 7.51B 6.56B 6.35B 5.63B
Selling, General, and Administrative Expenses 1.46B 1.24B 1.04B 946.69M
Research & Development 1.76B 1.23B 1.07B 939.92M
Operating Income before D & A (EBITDA) 4.29B 4.09B 4.23B 3.74B
Depreciation & Amortization 278.21M 302.23M 265.48M 212.94M
Interest Income 0.00 66.58M 60.29M 42.40M
Other Income - Net -37.28M 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 3.97B 3.86B 4.02B 3.57B
Interest Expense 360.92M 205.42M 108.96M 69.66M
Pre-Tax Income 3.61B 3.65B 3.91B 3.50B
Income Taxes 1.04B 861.94M 1.02B 876.36M
Minority Interest -17.97M -14.58M -11.51M -10.16M
Net Income From Continuing Operations 2.57B 0.00 0.00 2.64B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.57B 0.00 0.00 2.64B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.59B 2.80B 2.90B 2.64B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 2.57B 0.00 0.00 2.64B
Preferred Dividends
Net Income Available To Common 2.57B 0.00 0.00 2.64B
Basic EPS from Continuing Ops. 1.71 1.81 1.70 1.46
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.71 1.81 1.70 1.46
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.71 1.81 1.70 1.46
Basic Normalized Net Income/Share 1.71 n.a. n.a. 1.46
EPS fr Continuing Ops. 1.64 1.78 1.66 1.41
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.64 1.78 1.66 1.41
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.64 1.78 1.66 1.41
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 1.64 n.a. n.a. 1.41
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GILD

View All

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter